Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs

(2020) Katherine N. Theken et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?

(2020) Roos van Westrhenen et al.   Frontiers in Psychiatry

Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework

(2020) Cathelijne H. van der Wouden et al.   Journal of Clinical Medicine

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

(2020) John J. Lima et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update

(2020) Jason H. Karnes et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions

(2020) Chih-Jung Chang et al.   Frontiers in Pharmacology

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention

(2020) Naveen L. Pereira et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions

(2020) David J. Moliterno et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice

(2020) Stefan Russmann et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2019) F Cardoso et al.   ANNALS OF ONCOLOGY

Use of Pharmacogenetic Drugs by the Dutch Population

(2019) Mohammad A. Alshabeeb et al.   Frontiers in Genetics

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI

(2019) Daniel M.F. Claassens et al.   NEW ENGLAND JOURNAL OF MEDICINE

Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

(2019) Kelly E. Caudle et al.   CTS-Clinical and Translational Science

Coverage of pharmacogenetic tests by private health insurance companies

(2019) Sharon K. Park et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

(2018) Matthew P. Goetz et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

(2018) Elizabeth J. Phillips et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

(2018) Britt I. Drögemöller et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

(2018) Mary V. Relling et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)

(2016) Kelly E. Caudle et al.   GENETICS IN MEDICINE

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

(2016) Lyndsay N. Harris et al.   JOURNAL OF CLINICAL ONCOLOGY

Preemptive Pharmacogenomic Testing for Precision Medicine

(2016) Yuan Ji et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing

(2015) KA Birdwell et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Interethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populations

(2015) I Fricke-Galindo et al.   PHARMACOGENOMICS JOURNAL

Primary care physicians' knowledge of and experience with pharmacogenetic testing

(2012) SB Haga et al.   CLINICAL GENETICS

Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping

(2012) J S Schildcrout et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenomics Knowledge for Personalized Medicine

(2012) M Whirl-Carrillo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenetics of drug-induced liver injury

(2010) Stefan Russmann et al.   HEPATOLOGY

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine

(2010) Giovanna Gentile et al.   JOURNAL OF HEADACHE AND PAIN

Very important pharmacogene summary

(2010) Laura M. Hodges et al.   Pharmacogenetics and Genomics

HLA-B*5701 Screening for Hypersensitivity to Abacavir

(2008) Simon Mallal et al.   NEW ENGLAND JOURNAL OF MEDICINE